aztreonam · Bristol Myers Squibb · NDA 050632
Azactam In Plastic Container
Earliest generic entry, as listed · earliest of 2 marketed strengths
Open now
No marketed reference-listed strength; date taken from all listed strengths.
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- Generic approved · ANDA 207069, Hikma · 050632-001Approved 5 Feb 2026Detected 25 Oct 2026Historical import
Products covered · 3
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 050632 · 001 · RLD · discontinued | injectable, injection | 40MG/ML | open |
| 050632 · 002 · RLD · discontinued | injectable, injection | 20MG/ML | open |
| 050632 · 003 · discontinued | injectable, injection | 10MG/ML | open |